Doximity, Inc. - DOCS STOCK NEWS

Doximity, Inc. (NYSE: DOCS) announced its participation in two upcoming virtual investor events. The first event is the Piper Sandler 33rd Annual Healthcare Conference, scheduled for November 22, 2021, featuring a pre-recorded presentation by Dr. Nate Gross at 10:00 am ET. The second event is the Raymond James Technology Conference on December 6, 2021, with a presentation by CFO Anna Bryson at 4:50 pm ET. Both presentations will be webcasted, with access available on Doximity's investor relations website.

Doximity, Inc. (DOCS) reported strong Q2 FY2022 results, with revenue of $79.4 million, a 76% increase year-over-year. Net income surged to $36.1 million, reflecting a 45% margin. The company achieved a record 173% net revenue retention rate and over 330,000 active telehealth providers. Doximity projects Q3 revenue between $85.8 million and $86.8 million and FY2022 revenue between $326.1 million and $328.1 million. The lock-up period for insiders will expire on November 12, 2021, allowing for potential share sales.

Doximity, Inc. (NYSE:DOCS) will announce its financial results for the second quarter ending September 30, 2021, on November 9, 2021, after market close. A conference call and webcast will take place at 2:00 p.m. PT (5:00 p.m. ET) on the same day to discuss these results. Founded in 2010, Doximity is a leading digital platform that serves over 80% of U.S. physicians, providing essential tools for collaboration, medical news, and virtual patient visits.

Doximity, Inc. (NYSE: DOCS) has launched its 2021-2022 Residency Navigator tool, which is extensively utilized by U.S. medical students. The tool offers insights on over 4,900 residency programs and includes a new Couples Match Tool, designed to help partners find geographically close residency options. The platform contains valuable features like Neighborhood Insights, personalized searches, real reviews from residents, and detailed program statistics, facilitating informed decisions for medical students.

Doximity will participate in a virtual fireside chat at Morgan Stanley's 19th Annual Global Healthcare Conference on September 9, 2021, at 5:00 p.m. ET. CFO Anna Bryson will represent the company during this important industry event. The session will be available via webcast on Doximity's investor relations website, ensuring accessibility for stakeholders. Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals, serving over 80% of physicians across various specialties, aiming to enhance productivity and healthcare delivery.

Doximity, Inc. (DOCS) announced its fiscal Q1 2022 results, reporting a 100% year-over-year revenue increase to $72.7 million and net income of $26.3 million. The company achieved a 36% net income margin and a non-GAAP net income of $30.6 million (42% margin). Adjusted EBITDA soared 696% year-over-year to $31.2 million. Doximity ended the quarter with a strong cash position of $726.5 million following its IPO. The company forecasts Q2 revenue between $73 million and $74 million and full-year revenue guidance of $296.5 million to $299.5 million.

Doximity, Inc. (NYSE: DOCS) is set to announce its financial results for Q1 fiscal 2022, ending June 30, 2021, after the market closes on August 10, 2021. The company will hold a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss these results. Doximity is a leading digital platform for U.S. medical professionals, boasting over 80% of U.S. physicians as members. The company's mission is to enhance doctors' productivity to improve patient care.

Doximity, Inc. has priced its initial public offering (IPO) of 23.3 million shares of Class A common stock at $26.00 per share. The total gross proceeds to Doximity from the offering are projected to be approximately $494.3 million, excluding underwriting discounts and expenses. The offering includes 19 million shares sold by Doximity and 4.3 million shares from an existing stockholder. Trading under the ticker symbol 'DOCS' is set to begin on June 24, 2021, with the offering closing on June 28, 2021, pending customary conditions.

Doximity, a leading digital platform for U.S. medical professionals, has launched the roadshow for its initial public offering (IPO) of 23,300,000 shares of Class A common stock. The offering comprises 19,010,750 shares from Doximity and 4,289,250 shares from an existing stockholder. The expected IPO price ranges from $20.00 to $23.00 per share, with an overallotment option for underwriters to purchase up to an additional 3,495,000 shares. Doximity's shares will be traded on the New York Stock Exchange under the ticker symbol "DOCS."